These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23918685)

  • 1. Increased cardiovascular risk in South African patients with Addison's disease.
    Ross IL; Bergthorsdottir R; Levitt NS; Schatz DA; Johannsson G; Marais AD
    Horm Metab Res; 2013 Nov; 45(12):905-10. PubMed ID: 23918685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors in patients with Addison's disease: a comparative study of South African and Swedish patients.
    Ross IL; Bergthorsdottir R; Levitt N; Dave JA; Schatz D; Marais D; Johannsson G
    PLoS One; 2014; 9(6):e90768. PubMed ID: 24603607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male and female hypogonadism are highly prevalent in South Africans with Addison's disease.
    Ross IL; Levitt NS; Blom DJ; Haarburger D
    Horm Metab Res; 2014 Sep; 46(10):691-6. PubMed ID: 24799025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of glucocorticoid receptor polymorphisms in relation to metabolic parameters in Addison's disease.
    Ross IL; Levitt NS; Van der Merwe L; Schatz DA; Johannsson G; Dandara C; Pillay TS; Blom DJ
    Eur J Endocrinol; 2013 Mar; 168(3):403-12. PubMed ID: 23239757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9β Polymorphism of the glucocorticoid receptor gene appears to have limited impact in patients with Addison's disease.
    Ross IL; Dandara C; Swart M; Lacerda M; Schatz D; Blom DJ
    PLoS One; 2014; 9(1):e86350. PubMed ID: 24466047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
    Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS
    Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile.
    Asegaonkar SB; Marathe A; Tekade ML; Cherekar L; Bavikar J; Bardapurkar J; Ajay R
    J Diabetes Complications; 2011; 25(6):368-70. PubMed ID: 22055258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between C-reactive protein, pro-oxidant-antioxidant balance and traditional cardiovascular risk factors in an Iranian population.
    Razavi A; Baghshani MR; Rahsepar AA; Mohaddes Ardabili H; Sheikh Andalibi MS; Reza Parizadeh SM; Tavallaie S; Mousavi S; Ghayour-Mobarhan M; Ferns G
    Ann Clin Biochem; 2013 Mar; 50(Pt 2):115-21. PubMed ID: 23440541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
    Healy H; Reith D; Morgan C; Clague A; Westhuyzen J
    Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug prescription patterns in patients with Addison's disease: a Swedish population-based cohort study.
    Björnsdottir S; Sundström A; Ludvigsson JF; Blomqvist P; Kämpe O; Bensing S
    J Clin Endocrinol Metab; 2013 May; 98(5):2009-18. PubMed ID: 23543658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral Fat and Novel Biomarkers of Cardiovascular Disease in Patients With Addison's Disease: A Case-Control Study.
    Bergthorsdottir R; Ragnarsson O; Skrtic S; Glad CAM; Nilsson S; Ross IL; Leonsson-Zachrisson M; Johannsson G
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4264-4272. PubMed ID: 28945861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of high-sensitivity C-reactive protein with cardiometabolic risk factors and micronutrient deficiencies in adults of Ouagadougou, Burkina Faso.
    Zeba AN; Delisle HF; Rossier C; Renier G
    Br J Nutr; 2013 Apr; 109(7):1266-75. PubMed ID: 22914173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns.
    Katulanda GW; Katulanda P; Adler AI; Peiris SR; Draisey I; Wijeratne S; Sheriff R; Matthews DR; Shine B
    Ann Clin Biochem; 2010 Jan; 47(Pt 1):29-34. PubMed ID: 19952033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
    Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Immunological Characteristics of Autoimmune Addison Disease: A Nationwide Swedish Multicenter Study.
    Dalin F; Nordling Eriksson G; Dahlqvist P; Hallgren Å; Wahlberg J; Ekwall O; Söderberg S; Rönnelid J; Olcén P; Winqvist O; Catrina SB; Kriström B; Laudius M; Isaksson M; Halldin Stenlid M; Gustafsson J; Gebre-Medhin G; Björnsdottir S; Janson A; Åkerman AK; Åman J; Duchen K; Bergthorsdottir R; Johannsson G; Lindskog E; Landin-Olsson M; Elfving M; Waldenström E; Hulting AL; Kämpe O; Bensing S
    J Clin Endocrinol Metab; 2017 Feb; 102(2):379-389. PubMed ID: 27870550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, abdominal obesity, and clustering of cardiovascular risk factors in South Korea.
    Park HS; Yun YS; Park JY; Kim YS; Choi JM
    Asia Pac J Clin Nutr; 2003; 12(4):411-8. PubMed ID: 14672864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired health-related quality of life in Addison's disease--impact of replacement therapy, comorbidities and socio-economic factors.
    Kluger N; Matikainen N; Sintonen H; Ranki A; Roine RP; Schalin-Jäntti C
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):511-8. PubMed ID: 24801591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement.
    Giordano R; Marzotti S; Balbo M; Romagnoli S; Marinazzo E; Berardelli R; Migliaretti G; Benso A; Falorni A; Ghigo E; Arvat E
    J Endocrinol Invest; 2009 Dec; 32(11):917-23. PubMed ID: 19620820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.